← Evidence map

ReviewTherapeutic advances in chronic disease2025

Metabolic dysfunction-associated steatotic liver disease: an emerging comorbidity in COPD.

Ali Al Dailaty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41024975